Tag Archives: oxaliplatin

A New Method to Treat Chemotherapy-Induced Neuropathic Pain

Posted on March 12, 2012 by wngai

If you are cancer patients and have to receive chemotherapy agents such as taxanes (paclitaxol- Taxol and docetaxel-Taxotere), vinca alkaloids (vinorelbine-Navelbine) and platinum compounds (cisplatin, carboplatin – Paraplatin and oxaliplatin – Eloxatin), it is likely that you might experience chemotherapy … Continue reading →

Posted in Anal Cancer, Bladder Cancer, Breast cancer, Cancer, Colorectal cancer, Endometrial Cancer, Esophageal Cancer, Gallbladder cancer, Gastric Cancer, Glioblastma, Head and Neck Cancer, Liver Cancer, Lung Cancer, Melanoma, Nasopharyngeal Cancer, Non Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate cancer, Renal Cancer, Small Cell Lung Cancer | Tagged , , , , , , , , , , , , , , , , | Comments Off on A New Method to Treat Chemotherapy-Induced Neuropathic Pain

New Hope for Patients with Advanced Metastatic Colorectal Cancer Patients

Posted on March 11, 2012 by wngai

Colorectal cancer is the fourth most common cancer in men and women with nearly 500,000 deaths due to colorectal cancer every year.  When detected early at localized stage I, the 5-year survival rate can reach 90%. At this stage, surgical … Continue reading →

Posted in Cancer, Colorectal cancer | Tagged , , , , , , , , , , , , , , , , , , | Comments Off on New Hope for Patients with Advanced Metastatic Colorectal Cancer Patients

New Treatment for Colorectal Cancer Patients with Liver Metastases

Posted on April 3, 2011 by wngai

In the past, bevacizumab (Avastin) plus FOLFOX (leucovorin, 5-fluorouracil, and oxaliplatin) is the mainstay treatment for colorectal cancer patients with metastases (Stage IV).  Even though the response rate of this regimen is impressive, less than 10% of Stage IV colorectal cancer … Continue reading →

Posted in Cancer, Colorectal cancer | Tagged , , , , , , , , , , | Comments Off on New Treatment for Colorectal Cancer Patients with Liver Metastases

Docetaxel (Taxotere) is Effective in Heavily Pretreated Nasopharyngeal Carcinoma Patients

Posted on March 6, 2011 by wngai

It is well-established that nasopharyngeal carcinoma (NPC) is a chemo-responsive disease.  Despite improved outcome with chemo-radiation (platimum-based chemotherapy with radiation), treatment failure continue to be a problem in patients with locally advanced Stage III/IV disease.  Now, a new study published … Continue reading →

Posted in Cancer, Nasopharyngeal Cancer | Tagged , , , , , , , | Comments Off on Docetaxel (Taxotere) is Effective in Heavily Pretreated Nasopharyngeal Carcinoma Patients

Pancreatic cancer – Causes, Prevention, Prognosis, Diagnosis and Latest Treatment

Posted on April 17, 2010 by wngai

Prevalence Pancreatic cancer is the fourth most common cause of adult cancer death, accounting for an estimated 42,470 new cases and 35,240 deaths in USA for 2009.  The high mortality rate is due to the high incidence of metastatic disease … Continue reading →

Posted in Pancreatic Cancer | Tagged , , , , , , , , , , , , , , , , | 2 Comments